Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Exec appointment
confidence 92%
filed 2026-09-01
The 6-K discloses the appointment of Ms. Yue Zhuo as Chief Financial Officer effective September 1, 2026, following the resignation of Mr. Chaowei Yan on August 31, 2026. While both a departure and appointment occur, the principal disclosed action is the appointment of a named executive to a C-suite role. The disclosure includes Ms. Zhuo's background, qualifications, and tenure at the Company, consistent with exec_appointment guidance. CFO changes are material to investors assessing financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
The filing discloses the appointment of four new independent directors (Richard O'Brien, Marcelo Godoy, Josh Olmsted, and Blake Rhodes) to Hycroft's Board, effective September 1, 2026, expanding the Board from five to nine directors. O'Brien was also appointed Lead Independent Director. This is a material governance event affecting board composition and leadership structure, with the appointees bringing substantial industry experience from major mining companies (Newmont, AngloGold Ashanti, Freeport-McMoRan).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-01
The filing discloses the appointment of Liu Ming Hui as Chairman and Liu Ming Xing as Chief Executive Officer of HWH International Inc., effective September 1, 2026. While Chan Heng Fai's resignation as Chairman and CEO is also mentioned, the primary focus and substance of the disclosure centers on the appointment of the two new executives to lead the company. Both appointees are newly appointed board members (as of August 10, 2026) and bring significant international business experience from China Gas Holdings Limited, a major Hong Kong-listed company. This executive leadership transition is material to investors as it represents a fundamental change in the company's top management.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
Nick Konat, current president and COO, was appointed as Chief Executive Officer and Board member effective January 4, 2027, following a comprehensive Board succession process. Jack Sinclair transitioned to Executive Chairman. The appointment represents a material leadership change at the company's highest level.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-09-01
Item 5.02
Quantum Corporation appointed Hiral A. Patel as Chief Accounting Officer and Principal Accounting Officer, effective September 1, 2026. Ms. Patel's compensation package includes a base salary of $335,000, a 50% target bonus, and 50,000 restricted stock units.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-09-01
AstraZeneca announced the appointment of Wan Ling Martello as a Non-Executive Director effective 1 September 2026, with membership on the Audit Committee. This is a clear executive appointment to the board of a major pharmaceutical company, and the disclosure includes biographical details and a statement from the Chair endorsing her qualifications. Board appointments at large-cap public companies are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-01
Item 5.02
Lisa Wolf was appointed to the expanded roles of President and Chief Operating Officer in addition to her existing Chief Financial Officer role, and Jared Malbin and Thomas Jensen were appointed as directors to the Board, effective August 27, 2026, following the departure of former CEO Michael K. Handley.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
The Board appointed Stephan May as a director effective August 27, 2026, and appointed him to the Compensation and Human Resources Committee. The appointment is material as it involves a director-level position designated by major shareholder Siemens Industry under a Stockholders Agreement and fills a vacancy created by a prior resignation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-01
Item 5.02
The filing discloses both a departure (Mark Klingensmith resigning as CFO and Treasurer effective September 1, 2026) and an appointment (Siddhartha Chowdhury appointed to the same roles on the same date). While both events occur, the appointment is the principal forward-looking disclosure—the Board's action to fill the vacancy with a named successor whose qualifications and background are detailed. The appointment of a CFO is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-31
Item 8.01
The Board appointed Byron Pollan to the newly created position of Senior Vice President and Deputy Chief Financial Officer effective September 1, 2026, with a planned succession to Chief Financial Officer in mid-2027 upon Ron Copher's retirement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-31
Item 5.02
Martin Franc has been appointed as Senior Managing Director and Head of Asia Pacific, succeeding Andrew Lo who will retire effective March 31, 2027, after 32 years with Invesco. This represents material succession planning for a key executive position overseeing a significant regional business.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-31
EX-99.1
The media release announces the appointment of three non-executive directors—Stephan B. Tanda, Denise C. Johnson, and Robert Schuchna—to the combined company Board upon completion of the pending AkzoNobel-Axalta merger. The disclosure explicitly states these individuals "have agreed to serve as non-executive Directors of the combined company" and details their qualifications and roles. This is a governance event involving executive/director appointments material to the merged entity's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-31
Item 5.02
The filing discloses the appointment of Quentin Blackford, an experienced healthcare executive (currently CEO of iRhythm Technologies), to Align Technology's Board of Directors effective August 27, 2026. While the section also mentions Andrea L. Saia's resignation, the principal disclosed action centers on the appointment of a new director. Blackford's appointment is material as it represents a change in board composition and governance at a large-cap medical device company, and his background in healthcare and digital innovation is relevant to investor assessment of board quality and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 7.01
Wendy Reynolds-Dobbs was appointed to serve as Senior Vice President & Chief Human Resources Officer, effective September 14, 2026. This is a named executive appointment to a C-suite role. While the filing also mentions Jed Milstein's transition out of the same role, the principal disclosed action centers on Reynolds-Dobbs taking the position, making this an exec_appointment rather than a departure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-31
EX-99.1
The press release announces the appointment of Chris Benecchi as Chief Operating Officer of Inventiva, effective August 31, 2026. This is a clear executive appointment of a named officer to a C-suite role. The appointment is material because it occurs at a critical juncture—as the company approaches Phase 3 topline results for its lead candidate lanifibranor (expected Q4 2026) and prepares for potential commercialization in 2028—and Benecchi brings 30 years of biopharmaceutical leadership with direct experience in launch readiness and commercial operations.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-31
EX-99.1
The exhibit announces the appointment of Yoav Har-Even as Chairperson of the Board of Directors, effective immediately. While the prior Chairperson Amichai Steimberg stepped down, the principal disclosed action is Har-Even's appointment to the chair role. His extensive background as former President & CEO of Rafael Advanced Defense Systems and retired IDF Major General, combined with the Board's stated rationale that his appointment "reflects the strategic weight defense and security now carry for Innoviz," makes this a material governance change affecting board leadership at a public company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
Charles A. "Chuck" Parcher has assumed the role of President and Chief Executive Officer of Civista Bancshares, Inc. effective August 31, 2026, completing a previously announced leadership transition. While Dennis Shaffer's retirement as President and CEO is also disclosed, the principal action disclosed is Parcher's appointment to the CEO role, making this an exec_appointment event. The appointment of a new CEO is material to investors as it represents a significant change in leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
The filing discloses the Board's appointment of Dominic E. Dragisich as President and CEO effective August 31, 2026, and his concurrent appointment as a director. While the filing also mentions Patrick S. Pacious's resignation as former President and CEO, the principal disclosed action centers on Dragisich's appointment to the top executive role and the Board. The compensation details and amended severance agreement are ancillary to the core appointment event. This is material as it represents a permanent leadership transition for the company's chief executive.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-31
Item 5.02
The filing discloses the appointment of Brian J. Comstock as Chief Executive Officer and President of Greenbrier, effective January 6, 2027, following the Board's succession planning process. While the section also mentions Lorie Tekorius's retirement, the principal action disclosed is Comstock's appointment to the CEO role, which is the forward-looking material event. The filing emphasizes the Board's deliberate succession process and Comstock's qualifications and experience, making the appointment the salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-31
Item 5.02
The Board appointed Kristopher R. Westbrooks as President and Chief Executive Officer and Board member effective January 1, 2027, succeeding Michael S. Williams who is retiring effective December 31, 2026. The filing discloses detailed compensation arrangements for Westbrooks in his new role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
The disclosure centers on the appointment of Tommy E. Darby as Vice President, Chief Accounting Officer of Westlake Corporation, effective immediately on August 31, 2026. While the filing also includes compensatory details (salary of $440,000, bonus targets, and a $135,000 sign-on RSU award), the principal action is the appointment of a named executive officer to a key financial leadership role. The transition of Jeffrey A. Holy to a different position is secondary to Darby's appointment. This is material as it involves a change in the chief accounting officer position, a critical role for financial reporting and internal controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
Tommy E. Darby was appointed to the position of Vice President, Chief Accounting Officer of Westlake Chemical Partners GP LLC (the general partner) effective immediately on August 31, 2026, and concurrently to the same role at Westlake Corporation. This is a material executive appointment to a senior financial officer position responsible for accounting oversight. While Jeffrey A. Holy's transition to a different role is also mentioned, the principal disclosed action centers on Darby's appointment to the Chief Accounting Officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-08-31
Item 5.02
Kohl's appointed Ryan M. Waymire as Chief Merchandising Officer effective September 28, 2026, reporting directly to CEO Michael J. Bender. Waymire brings 25 years of retail leadership experience from Walmart, Amazon, Target, and other major retailers. The appointment was announced via press release and represents a significant governance event affecting leadership continuity and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
On August 25, 2026, four independent directors—Verender S. Badial, Christopher Staral, Dr. Arjun Goyal, and Dr. Jonathon Kluft—were appointed to the Board and simultaneously appointed to chair or serve on the Audit, Compensation, and Nominating and Corporate Governance Committees in connection with the IPO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
Morris Berger was appointed as Chief Executive Officer effective October 1, 2026, with Jonathan Reich transitioning from CEO to President and Chief Operating Officer. The appointment includes a $450,000 base salary, $50,000 signing bonus, and equity options equal to 3% of outstanding shares, supported by a $7.5 million insider investment by Berger.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.08
The material event disclosed is the appointment of independent director Lee McIntire as Chief Executive Officer, effective August 11, 2026. While the Item 5.08 section addresses routine shareholder meeting logistics and nomination deadlines, the substantive disclosure in Item 8.01 (Other Events) centers on McIntire's appointment to the CEO role—a senior executive appointment that would materially affect investor assessment of the company's leadership. The associated Audit Committee changes (McIntire's resignation and Stein's appointment) are secondary governance adjustments flowing from the CEO appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-31
Item 5.02
The filing discloses both the departure of CEO Katharyn Field and the appointment of Shahin Behroyan as Chief Executive Officer, effective August 26, 2026. While both events occurred, the principal disclosed action centers on the appointment of a new CEO with detailed background, qualifications, and a new Independent Contractor Agreement ($350,000 annual fee). The appointment of a new chief executive is material to investors and represents the salient event, though the departure is also disclosed.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-31
EX-99.1
The announcement discloses two executive appointments: Ms. Diana Marcela Acero Rojas as Acting Corporate Vice President of Science, Technology and Innovation (effective September 1, 2026) and Mr. Henryk Manuel Porras Villamil as Acting Executive Vice President of Energy Transition (effective August 31, 2026). While both are interim/acting roles, they represent formal Board-adopted resolutions elevating individuals to senior management positions. The disclosure also mentions departures (Mr. Moreno ceasing his role and Mr. Gómez Cabarcas taking statutory leave), but the principal disclosed action is the appointment of two executives to Vice President-level roles, making exec_appointment the primary classification. These are material changes to senior leadership at a major integrated energy company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
The filing discloses the appointment of two directors, James A. Greer and Oscar K. Brown, to Primoris' Board of Directors effective October 1, 2026, with the Board voting to increase authorized directors to ten members. This is a clear executive appointment event under Item 5.02, with both appointees bringing substantial industry experience (Greer with 40+ years in energy delivery and prior COO role at Oncor; Brown with 25+ years in energy and current CEO of Western Midstream). The appointment of experienced directors to a public company board is material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-31
Item 5.02
Michael Grasher was appointed as Chief Financial Officer of Teladoc Health effective August 31, 2026, replacing interim CFO Charles Divita III. The appointment includes a $550,000 base salary, $500,000 sign-on bonus, and $3,000,000 in equity awards, reflecting his extensive financial leadership experience including prior CFO roles at AMERISAFE, Fortegra, and IFG Companies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-31
Item 5.02
Sean Valashinas was appointed as acting Chief Financial Officer effective immediately, following Willard Station's medical leave of absence from the CFO role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 70%
filed 2026-08-31
Item 5.02
Wilfredo Ramos was appointed as Gutmann's successor to lead International, Healthcare and Supply Chain Solutions, and other executive role changes were made as part of organizational restructuring.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-31
EX-99.1
David Gill has been appointed Chair of the Telix Board effective immediately, succeeding interim Chair Dr. Mark Nelson. The announcement explicitly states "David Gill has been appointed Chair of the Board, effective immediately" and describes his extensive background in life sciences leadership and capital markets expertise. This is a material executive appointment to the highest governance position at the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-31
Item 5.02
The section discloses both a director resignation (Naytri Shroff Sramek, effective August 27, 2026) and a director appointment (Jason Karp, appointed August 27, 2026 to Class III). While both events occur, the appointment of Jason Karp—a founder and CEO with significant consumer brand and investment management experience—is the more substantive disclosure and represents the principal action the company is highlighting. The detailed background on Karp's qualifications and the Board's rationale for his appointment indicate this is the focal event, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-08-31
Item 5.02
Robert Winspear was appointed Chief Financial Officer effective August 25, 2026, with a base salary of $285,000, equity awards of 30,000 RSUs and 15,000 stock options, and severance terms. Marc Jarvis was appointed to the board effective August 28, 2026. These appointments bring significant public company and energy sector experience to the company's leadership as it enters the oil and gas sector.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
Steven W. Presley was elected to Altria's Board of Directors effective August 27, 2026, and appointed to three Board committees: Compensation and Talent Development, Innovation, and Finance. Presley is the CEO of Refresco Benelux and former senior executive at Nestlé.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
On August 26, 2026, Wing C. ('Andrew') Lam, PharmD and Chidozie Ugwumba were appointed to the board of directors in connection with the effectiveness of the Registration Statement for the Company's IPO, with assignments to board committees.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-28
EX-99.1
Ms. Tianjing Zhang was appointed as an independent director effective August 29, 2026, and Mr. David Zhang was re-designated as an independent director under Hong Kong Listing Rules. These board composition changes affecting independent director status are material governance events.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-28
Item 5.02
The disclosure centers on the Board's appointment of Alicia Pfeifer and Brett Coburn as co-Chief Financial Officers on an interim basis, effective September 1, 2026. While the section also includes compensatory details (a $10,000 monthly stipend), the principal disclosed action is the appointment of these two executives to a material C-suite role. This is a significant leadership change affecting the company's financial reporting structure and would materially affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-28
Item 5.02
IonQ appointed two new directors to its Board of Directors effective August 24, 2026: Dr. Eric R. Ball, who brings 40 years of senior financial experience at AT&T, Cisco, and Oracle, and Timothy E. Baxter, with 40+ years leading major technology companies including as Samsung CEO. Both appointments are material governance events reflecting strategic leadership additions to support IonQ's quantum computing manufacturing expansion.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-28
The filing discloses the election of Mr. Zhanli Wang as director, Chairman, CEO, and CFO effective August 28, 2026, following the resignation of Mr. Guangsheng Liu from those same positions. While both a departure and appointment occur, the principal disclosed action is the appointment of Wang to multiple senior leadership roles, making exec_appointment the primary classification. The simultaneous assumption of Chairman, CEO, and CFO roles by a single individual is material to investors' assessment of governance and leadership continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-28
Item 5.02
The filing discloses the appointment of Jerry Leonard as Chief Financial Officer effective September 1, 2026, along with a consulting agreement between the Company and ClearbridgeCFO, LLC for his services at $15,000 per month. While the section also mentions Robert Dickey's resignation as Interim CFO, the principal disclosed action centers on the appointment of a new CFO with a defined compensation arrangement, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
Joseph Long is being appointed as Executive Vice President, Chief Operating Officer and Chief Credit Officer, effective September 14, 2026, with detailed employment terms including base salary of $333,000, bonus structure, and severance provisions. While Kevin Comps's duties are transitioning, the principal disclosed action centers on Long's appointment to these senior executive roles, making this an exec_appointment event. The appointment is material as it involves a significant leadership change at the C-suite level for a publicly traded bank.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-28
Item 5.02
The filing discloses both the departure of CFO Julia Brau Donnelly (effective October 30, 2026) and the appointment of Vikram Naidu as Principal Financial Officer on an interim basis (effective the same date). While both events are disclosed, the principal forward-looking action is the appointment of Naidu to the CFO role, making this an exec_appointment. The departure is contextual background explaining why the appointment is necessary. This is material because it involves a change in the Company's chief financial officer, a key executive position affecting investor confidence and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-28
Item 5.02
Peter Owino was appointed Chief Accounting Officer effective September 1, 2026, following his service as Interim Chief Accounting Officer. The appointment includes a base salary of $350,000, bonus targets, 100,000 restricted stock awards as inducement equity, and severance provisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-08-28
Item 5.02
Lucid appointed three senior executives: Shawn Mirabal as President of North America Commercial, Mike Molino as Vice President of Finance, and Angela Zepeda as Vice President, Global Marketing, to strengthen commercial execution, financial discipline, and customer engagement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
Ray Pittard was elected to the Board of Directors on August 25, 2026, to fill a vacancy created by the Board's expansion from twelve to thirteen directors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-27
EX-99.1
The exhibit announces the appointment of Arek Nowinski to Polestar's Board of Directors, replacing retiring director Francesca Gamboni. This is a discrete governance event involving a director taking a role. While the announcement also mentions a departure (Gamboni's retirement), the principal disclosed action is the appointment of a new board member, making exec_appointment the appropriate classification. Board composition changes are material to investors assessing corporate governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-27
Item 5.02
The filing discloses both the departure of Lawrence A. Kenyon as CFO, Treasurer, and Corporate Secretary effective September 1, 2026, and the appointment of Kevin Lundquist as CFO, Treasurer, principal financial officer and principal accounting officer effective the same date. While both events occur, the principal disclosed action centers on the appointment of Lundquist with detailed compensation arrangements (base salary $450,000, 500,000 stock options, severance terms), making exec_appointment the most salient classification. The departure is secondary context to the transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-27
Item 5.02
Chris Boynton was appointed as Executive Vice President and Chief Financial Officer effective September 14, 2026, bringing 20+ years of aerospace and defense industry experience including prior CFO roles at Battelle and RTX. The appointment includes a base salary of $750,000, sign-on bonus of $500,000, equity grants, and severance provisions. Mike Willis's departure as CFO by year-end is a secondary disclosure within this appointment event.
View raw filing on EDGAR →